Can Granules India leverage its strong product pipeline to offset recent profit declines?

August 22, 2025

Granules India’s stock shows a slight recovery despite reporting lower profits in the June quarter. Investors are positive about the company’s product pipeline and business stabilisation. The company anticipates better growth in FY27. Approvals for six products in Europe are awaited. Granules focuses on CNS, ADHD, and oncology products. The Gagillapur facility remediation is progressing well with US FDA.

More To Explore

Axis Bank shares rise 2% as lender set to invest Rs 1,500 crore into NBFC arm Axis Finance

Axis Bank shares gained after the lender approved a Rs 1,500 crore capital infusion into its NBFC arm, Axis Finance. The move follows a pause

March 18, 2026

Dharmesh Shah advises buying on dips, sees favourable risk-reward ahead

Dalal Street shows improved sentiment after three consecutive gains, but experts caution it’s a technical pullback from oversold levels, not a full recovery. While historical

March 18, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003